Product Information
AMPHETAMINE ER 15.7 MG ODT is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $16.0418 per EA under NDC 00480331965. Its NADAC has been published 30 times since Jan 28, 2026.
FDA first approved this application on Jun 22, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
15.7 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480331965
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
AMPHETAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA209253FDA Approved
6/22/2023
TE Code
AB
On Market Since
12/8/2025
Pharmacological Classes
Price Statistics
The NADAC for AMPHETAMINE ER 15.7 MG ODT has been published 30 times since Jan 28, 2026, and over the history we have for it it has declined 2.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.0418 per EA |
|---|---|
| All-time high | $16.5381 (Apr 15, 2026) |
| All-time low | $15.9385 (Jul 22, 2026) |
| 52-week high | $16.5381 |
| 52-week low | $15.9385 |
| Median price | $16.3645 |
| Average price | $16.2646 |
| Largest weekly change | -1.3% (May 20, 2026) |
| Weeks tracked | 30 |
| Tracking since | Jan 28, 2026 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of AMPHETAMINE ER 15.7 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for AMPHETAMINE ER 15.7 MG ODT, manufactured by Teva Pharmaceuticals USA Inc., is $16.0418 per EA (NDC 00480331965), effective Aug 19, 2026.
How has the price of AMPHETAMINE ER 15.7 MG ODT changed over time?
Over the history we have for it, the NADAC for AMPHETAMINE ER 15.7 MG ODT has declined 2.9%. It has been tracked across 30 weekly CMS publications since Jan 28, 2026.
What are the highest and lowest recorded NADAC prices for AMPHETAMINE ER 15.7 MG ODT?
Since Jan 28, 2026, the NADAC for AMPHETAMINE ER 15.7 MG ODT has ranged from a low of $15.9385 (Jul 22, 2026) to a high of $16.5381 (Apr 15, 2026), with a median of $16.3645 per EA.
Are there cheaper alternatives to AMPHETAMINE ER 15.7 MG ODT?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as AMPHETAMINE ER 15.7 MG ODT in a comparable dosage form, but none are currently priced below it.
Who manufactures AMPHETAMINE ER 15.7 MG ODT?
AMPHETAMINE ER 15.7 MG ODT (NDC 00480331965) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.